Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in

Synthesis Capital

WebsiteLinkedIncbCrunchbase
Status
ACTIVE
Global HQ
London, United Kingdom
Countries of investment
  • United Kingdom
  • United States
  • Singapore
Investment stages
  • Seed
  • Series A
  • Growth
Industries
  • FoodTech
  • Biotechnology
  • Life Sciences
  • Climate Tech
About
Synthesis Capital, headquartered in London, invests in science-based foodtech startups revolutionizing protein production, fermentation, and precision biology for sustainable consumption.
Min check size
$100K
Max check size
$100M
Fund size
NPS

Investment Thesis

Synthesis Capital focuses on advancing alternative proteins and sustainable food systems through strategic investments in deep-tech and biotechnology.
Lead investor
Co Invest
Number of exits
Preferred contact method

Manager's Experience

Strong track record in growth-stage investments across agtech, foodtech, and sustainability sectors.

Synthesis Capital Contacts Information

Primary contact

Team

Costa Yiannoulis - Managing Partner Co-Founder

Rosie Wardle - Partner Co-Founder

Dr. David Welch - Chief Scientific Officer Co-Founder

Andreas Hadjiyannis - Director of Finance and Operations

Shivani Oberoi - Principal

Steve Molino - Principal

Amanda Schaible - Senior Associate

Georgina Sánchez Moles - Analyst

Will Davis - Operations and Culture (Consultant)

Gina Boswell - Advisory Board

Mark Matlock - Advisory Board

Portfolio

TeraPore Technologies

Perfect Day Foods

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp